Predicting survival in ambulatory patients with severe heart failure on beta-blocker therapy.
Peak VO(2) and the Heart Failure Survival Score are 2 clinical parameters used to risk stratify patients with heart failure and time listing for cardiac transplantation. The efficacy of these prognostic variables in patients receiving beta-blocker therapy was evaluated.
Lund
Lars H
LH
Department of Medicine, Columbia University, New York, New York, USA.
Aaronson
Keith D
KD
Mancini
Donna M
DM
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D016027:Heart Transplantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D010101:Oxygen Consumption / Q000502:physiology; D011237:Predictive Value of Tests; D011379:Prognosis; D018570:Risk Assessment; D016019:Survival Analysis
D000319:Adrenergic beta-Antagonists